Dotson R G, Pingleton S K
Department of Internal Medicine, University of Kansas Medical Center, Kansas City.
Chest. 1993 Feb;103(2):541-6. doi: 10.1378/chest.103.2.541.
Intracellular bacteria (ICB) within recovered cells (> 7 percent) obtained via bronchoalveolar lavage (BAL) have been described as predictive of subsequent positive quantitative protected specimen brush (PSB) cultures in patients not receiving antibiotics. To determine the effect of prior or current antibiotic therapy on ICB relative to subsequent PSB culture, we prospectively evaluated 49 consecutive episodes of clinically suspected ventilator-associated pneumonia in 36 patients. Three patient groups were defined based on antibiotic administration: group 1 (current antibiotics), n = 31, samples obtained from patients currently receiving antibiotics; group 2 (recent antibiotics), n = 5, samples obtained from patients who received antibiotics > 48 h but < 72 h prior to sampling; and group 3 (no antibiotics), n = 13, samples from patients receiving no previous antibiotics within 7 days prior to sampling. Overall, PSB cultures (> or = 10(3) cfu/ml) were positive in 14 of 49 (29 percent) samples. In group 1, 2 of 31 (6 percent) samples were positive while 5 of 5 (100 percent) samples in group 2, and 7 of 13 (54 percent) in group 3 were positive. The presence or absence of ICB accurately predicted both positive and negative PSB cultures in 43 of 49 episodes. Of 43 correct predictions, 34 were negative predictions (negative ICB, negative PSB culture). The vast majority of these (29) were obtained from group 1, patients currently receiving antibiotics. In contrast, of nine positive predictions (+ICB, +PSB) virtually all (seven) occurred in group 3, patients receiving no antibiotics. In group 3, 13 of 13 PSB cultures were accurately predicted, either positive or negative, by the presence or absence of ICB. Of seven positive PSB cultures in groups 1 and 2, only 2 (28 percent) were accurately predicted by ICB. From both samples, the cultured organism was resistant to all administered antibiotics. These data suggest both prior and current antibiotic therapy reduces recovery of ICB from BAL and reduces predictive accuracy of ICB for subsequent positive PSB cultures. However, negative prediction by ICB for subsequent negative PSB cultures was good. In contrast, ICB obtained from patients not receiving antibiotics are highly predictive of subsequent PSB culture results, both positive and negative. We do not recommend BAL for evaluation of ICB in patients currently receiving antibiotics or with a recent history of antibiotic use.
通过支气管肺泡灌洗(BAL)获得的回收细胞内的细胞内细菌(ICB)(>7%)已被描述为未接受抗生素治疗患者后续定量保护性标本刷检(PSB)培养呈阳性的预测指标。为了确定既往或当前抗生素治疗对ICB相对于后续PSB培养的影响,我们前瞻性评估了36例患者连续49次临床疑似呼吸机相关性肺炎发作情况。根据抗生素使用情况定义了三组患者:第1组(当前使用抗生素),n = 31,样本取自当前正在接受抗生素治疗的患者;第2组(近期使用抗生素),n = 5,样本取自采样前48小时以上但不到72小时接受过抗生素治疗的患者;第3组(未使用抗生素),n = 13,样本取自采样前7天内未接受过抗生素治疗的患者。总体而言,49份样本中有14份(29%)PSB培养(≥10³ cfu/ml)呈阳性。在第1组中,31份样本中有2份(6%)呈阳性,而第2组的5份样本中有5份(100%)呈阳性,第3组的13份样本中有7份(54%)呈阳性。ICB的存在与否在49次发作中的43次准确预测了PSB培养的阳性和阴性结果。在43次正确预测中,34次为阴性预测(ICB阴性,PSB培养阴性)。其中绝大多数(29次)来自第1组,即当前正在接受抗生素治疗的患者。相比之下,在9次阳性预测(+ICB,+PSB)中,几乎所有(7次)都发生在第3组,即未接受抗生素治疗的患者。在第3组中,13份PSB培养结果,无论阳性或阴性,都通过ICB的存在与否得到了准确预测。在第1组和第2组的7次阳性PSB培养中,只有2次(28%)通过ICB得到了准确预测。从两份样本中培养出的微生物对所有使用的抗生素均耐药。这些数据表明,既往和当前的抗生素治疗均降低了BAL中ICB的回收率,并降低了ICB对后续PSB培养阳性结果的预测准确性。然而,ICB对后续PSB培养阴性结果的阴性预测效果良好。相比之下,从未接受抗生素治疗患者中获得的ICB对后续PSB培养结果,无论阳性还是阴性,都具有高度预测性。我们不建议对当前正在接受抗生素治疗或近期有抗生素使用史的患者进行BAL以评估ICB。